Premorbid adjustment and schizophrenia in individuals with 22q11.2 deletion syndrome

Schizophrenia Research

Volumn 151, Issue 1-3, 2013, Pages 221-225

  Yuen, Tracy ^a   Chow, Eva W C ^a,b   Silversides, Candice K ^c,d   Bassett, Anne S ^a,b,c,d  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

22q11.2 deletion syndrome; Premorbid adjustment; Schizophrenia

Indexed keywords

ACADEMIC ACHIEVEMENT; ACADEMIC FAILURE; ADOLESCENCE; ADULT; AGE DISTRIBUTION; ARTICLE; CHILDHOOD; CHROMOSOME DELETION 22Q11; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INTELLECTUAL IMPAIRMENT; NONHUMAN; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM; SOCIAL INTERACTION; YOUNG ADULT;

22Q11.2 DELETION SYNDROME; PREMORBID ADJUSTMENT; SCHIZOPHRENIA;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; DIGEORGE SYNDROME; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL BEHAVIOR; STATISTICS, NONPARAMETRIC;

EID: 84889090640     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.10.041     Document Type: Article

References (41)

1. Addington J., Addington D. Patterns of premorbid functioning in first episode psychosis: relationship to 2-year outcome. Acta Psychiatr. Scand. 2005, 112(1):40-46.
2. Allen D.N., Frantom L.V., Strauss G.P., van Kammen D.P. Differential patterns of premorbid academic and social deterioration in patients with schizophrenia. Schizophr. Res. 2005, 75(2-3):389-397.
3. Antshel K.M., Hendricks K., Shprintzen R., Fremont W., Higgins A.M., Faraone S.V., Kates W.R. The longitudinal course of attention deficit/hyperactivity disorder in velo-cardio-facial syndrome. J. Pediatr. 2013, 163(1):187-193.
4. Bassett A.S., Chow E.W., AbdelMalik P., Gheorghiu M., Husted J., Weksberg R. The schizophrenia phenotype in 22q11 deletion syndrome. Am. J. Psychiatry 2003, 160(9):1580-1586.
5. Bassett A.S., Chow E.W., Husted J., Weksberg R., Caluseriu O., Webb G.D., Gatzoulis M.A. Clinical features of 78 adults with 22q11 deletion syndrome. Am. J. Med. Genet. A 2005, 138(4):307-313.
6. Bassett A.S., Caluseriu O., Weksberg R., Young D.A., Chow E.W. Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome. Biol. Psychiatry 2007, 61(10):1135-1140.
7. Bassett A.S., Marshall C.R., Lionel A.C., Chow E.W., Scherer S.W. Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome. Hum. Mol. Genet. 2008, 17(24):4045-4053.
8. Bassett A.S., Chow E.W., Husted J., Hodgkinson K.A., Oechslin E., Harris L., Silversides C. Premature death in adults with 22q11.2 deletion syndrome. J. Med. Genet. 2009, 46(5):324-330.
9. Bassett A.S., Costain G., Fung W.L., Russell K.J., Pierce L., Kapadia R., Carter R.F., Chow E.W., Forsythe P.J. Clinically detectable copy number variations in a Canadian catchment population of schizophrenia. J. Psychiatr. Res. 2010, 44(15):1005-1009.
10. Bassett A.S., McDonald-McGinn D.M., Devriendt K., Digilio M.C., Goldenberg P., Habel A., Marino B., Oskarsdottir S., Philip N., Sullivan K., Swillen A., Vorstman J.A., International 22q11.2 Deletion Syndrome Consortium Practical guidelines for managing patients with 22q11.2 deletion syndrome. J. Pediatr. 2011, 159(2):332-339. (e1.).
11. Cannon M., Jones P., Gilvarry C., Rifkin L., McKenzie K., Foerster A., Murray R.M. Premorbid social functioning in schizophrenia and bipolar disorder: similarities and differences. Am. J. Psychiatry 1997, 154(11):1544-1550.
12. Cannon-Spoor H.E., Potkin S.G., Wyatt R.J. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr. Bull. 1982, 8(3):470-484.
13. Chow E.W., Watson M., Young D.A., Bassett A.S. Neurocognitive profile in 22q11 deletion syndrome and schizophrenia. Schizophr. Res. 2006, 87(1-3):270-278.
14. Costain G., Bassett A.S. Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era. Appl. Clin. Genet. 2012, 5:1-18.
15. Driscoll D.A., Salvin J., Sellinger B., Budarf M.L., McDonald-McGinn D.M., Zackai E.H., Emanuel B.S. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J. Med. Genet. 1993, 30(10):813-817.
16. Fung W.L., McEvilly R., Fong J., Silversides C., Chow E., Bassett A.S. Elevated prevalence of generalized anxiety disorder in adults with 22q11.2 deletion syndrome. Am. J. Psychiatry 2010, 167(8):998.
17. Goldberg T.E., Green M.F. Neurocognitive functioning in patients with schizophrenia: an overview. Neuropsychopharmacology-5th Generation of Progress 2002, 657. Lippincott, Williams & Wilkins, Philadelphia, Pennsylvania. K.L. David, D. Charney, J.T. Coyle, C. Nemeroff (Eds.).
18. Green T., Gothelf D., Glaser B., Debbane M., Frisch A., Kotler M., Weizman A., Eliez S. Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J. Am. Acad. Child Adolesc. Psychiatry 2009, 48(11):1060-1068.
19. Hafner H., Maurer K., Ruhrmann S., Bechdolf A., Klosterkotter J., Wagner M., Maier W., Bottlender R., Moller H.J., Gaebel W., Wolwer W. Early detection and secondary prevention of psychosis: facts and visions. Eur. Arch. Psychiatry Clin. Neurosci. 2004, 254(2):117-128.
20. Hans S.L., Auerbach J.G., Asarnow J.R., Styr B., Marcus J. Social adjustment of adolescents at risk for schizophrenia: the Jerusalem Infant Development Study. J. Am. Acad. Child Adolesc. Psychiatry 2000, 39(11):1406-1414.
21. Insel T.R. Rethinking schizophrenia. Nature 2010, 468(7321):187-193.
22. Jolin E.M., Weller R.A., Weller E.B. Occurrence of affective disorders compared to other psychiatric disorders in children and adolescents with 22q11.2 deletion syndrome. J. Affect. Disord. 2012, 136(3):222-228.
23. Kobrynski L.J., Sullivan K.E. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 2007, 370(9596):1443-1452.
24. Larsen T.K., McGlashan T.H., Johannessen J.O., Vibe-Hansen L. First-episode schizophrenia: II. Premorbid patterns by gender. Schizophr. Bull. 1996, 22(2):257-269.
25. Larsen T.K., Melle I., Auestad B., Haahr U., Joa I., Johannessen J.O., Opjordsmoen S., Rund B.R., Rossberg J.I., Simonsen E., Vaglum P., Friis S., McGlashan T. Early detection of psychosis: positive effects on 5-year outcome. Psychol. Med. 2011, 41(7):1461-1469.
26. MacBeth A., Gumley A. Premorbid adjustment, symptom development and quality of life in first episode psychosis: a systematic review and critical reappraisal. Acta Psychiatr. Scand. 2008, 117(2):85-99.
27. McClellan J., Breiger D., McCurry C., Hlastala S.A. Premorbid functioning in early-onset psychotic disorders. J. Am. Acad. Child Adolesc. Psychiatry 2003, 42(6):666-672.
28. Monte R.C., Goulding S.M., Compton M.T. Premorbid functioning of patients with first-episode nonaffective psychosis: a comparison of deterioration in academic and social performance, and clinical correlates of Premorbid Adjustment Scale scores. Schizophr. Res. 2008, 104(1-3):206-213.
29. Norman R.M., Malla A.K., Manchanda R., Townsend L. Premorbid adjustment in first episode schizophrenia and schizoaffective disorders: a comparison of social and academic domains. Acta Psychiatr. Scand. 2005, 112(1):30-39.
30. Norman R.M., Malla A.K., Manchanda R. Early premorbid adjustment as a moderator of the impact of duration of untreated psychosis. Schizophr. Res. 2007, 95(1-3):111-114.
31. Oskarsdottir S., Vujic M., Fasth A. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch. Dis. Child. 2004, 89(2):148-151.
32. Philip N., Bassett A.S. Cognitive, behavioural and psychiatric phenotype in 22q11.2 deletion syndrome. Behav. Genet. 2011, 41(3):403-412.
33. Preston N.J., Orr K.G., Date R., Nolan L., Castle D.J. Gender differences in premorbid adjustment of patients with first episode psychosis. Schizophr. Res. 2002, 55(3):285-290.
34. Rabinowitz J., Napryeyenko O., Burba B., Martinez G., Neznanov N.G., Fischel T., Bayle F.J., Cavallaro R., Smeraldi E., Schreiner A. Premorbid functioning and treatment response in recent-onset schizophrenia: prospective study with risperidone long-acting injectable. J. Clin. Psychopharmacol. 2011, 31(1):75-81.
35. Rapoport J.L., Addington A.M., Frangou S., Psych M.R. The neurodevelopmental model of schizophrenia: update 2005. Mol. Psychiatry 2005, 10(5):434-449.
36. Shapiro D.I., Marenco S., Spoor E.H., Egan M.F., Weinberger D.R., Gold J.M. The Premorbid Adjustment Scale as a measure of developmental compromise in patients with schizophrenia and their healthy siblings. Schizophr. Res. 2009, 112(1-3):136-142.
37. Shashi V., Veerapandiyan A., Schoch K., Kwapil T., Keshavan M., Ip E., Hooper S. Social skills and associated psychopathology in children with chromosome 22q11.2 deletion syndrome: implications for interventions. J. Intellect. Disabil. Res. 2012, 56(9):865-878.
38. Strauss G.P., Allen D.N., Miski P., Buchanan R.W., Kirkpatrick B., Carpenter W.T. Differential patterns of premorbid social and academic deterioration in deficit and nondeficit schizophrenia. Schizophr. Res. 2012, 135(1-3):134-138.
39. Vourdas A., Pipe R., Corrigall R., Frangou S. Increased developmental deviance and premorbid dysfunction in early onset schizophrenia. Schizophr. Res. 2003, 62(1-2):13-22.
40. Wechsler D. Wechsler Adult Intelligence Scale - (WAIS-3®) 1997, Harcourt Assessment, San Antonio, TX. 3rd edition.
41. Welham J., Isohanni M., Jones P., McGrath J. The antecedents of schizophrenia: a review of birth cohort studies. Schizophr. Bull. 2009, 35(3):603-623.